Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -0.09%5.57B | 5.71%12.06B | 6.56%5.57B | 5.68%11.41B | 6.87%5.23B | -4.86%10.79B | -6.78%4.89B | 9.19%11.34B | 9.35%5.25B | -3.26%10.39B |
| Operating income | -0.09%5.57B | 5.71%12.06B | 6.56%5.57B | 5.68%11.41B | 6.87%5.23B | -4.86%10.79B | -6.78%4.89B | 9.19%11.34B | 9.35%5.25B | -3.26%10.39B |
| Cost of sales | -4.24%-2.73B | -3.97%-5.6B | -4.39%-2.62B | -0.37%-5.38B | 1.73%-2.51B | 2.42%-5.36B | 2.19%-2.55B | -3.06%-5.5B | -2.64%-2.61B | 2.75%-5.33B |
| Operating expenses | -4.24%-2.73B | -3.97%-5.6B | -4.39%-2.62B | -0.37%-5.38B | 1.73%-2.51B | 2.42%-5.36B | 2.19%-2.55B | -3.06%-5.5B | -2.64%-2.61B | 2.75%-5.33B |
| Gross profit | -3.92%2.84B | 7.26%6.46B | 8.55%2.96B | 10.92%6.02B | 16.21%2.72B | -7.15%5.43B | -11.31%2.34B | 15.67%5.85B | 16.90%2.64B | -3.79%5.06B |
| Special items of operating profit | -6.42%-497M | 7.17%-971M | -9.88%-467M | -13.70%-1.05B | 8.21%-425M | 8.18%-920M | 6.46%-463M | -9.51%-1B | 2.56%-495M | 12.10%-915M |
| Operating profit | -5.86%2.34B | 10.29%5.49B | 8.31%2.49B | 10.36%4.98B | 22.22%2.3B | -6.93%4.51B | -12.43%1.88B | 17.03%4.85B | 22.53%2.15B | -1.73%4.14B |
| Financing cost | -0.59%-678M | -3.53%-1.41B | -4.50%-674M | -41.52%-1.36B | -61.65%-645M | -20.13%-961M | 0.25%-399M | 17.61%-800M | 18.03%-400M | 3.29%-971M |
| Earning before tax | -8.26%1.67B | 12.83%4.08B | 9.79%1.82B | 1.92%3.62B | 11.61%1.65B | -12.29%3.55B | -15.22%1.48B | 27.64%4.05B | 38.18%1.75B | -1.25%3.17B |
| Tax | 4.31%-311M | 18.48%-741M | -7.97%-325M | -386.10%-909M | -271.60%-301M | 54.72%-187M | 58.03%-81M | 8.63%-413M | -19.14%-193M | 17.37%-452M |
| Deferred tax | 162.50%5M | ---- | ---8M | 159.50%263M | ---- | -37.27%-442M | -54.10%-188M | -177.59%-322M | -60.53%-122M | -73.13%-116M |
| After-tax profit from continuing operations | -8.29%1.36B | 12.42%3.34B | 9.61%1.48B | 1.75%2.97B | 11.54%1.35B | -11.81%2.92B | -15.35%1.21B | 27.26%3.31B | 39.53%1.43B | 0.23%2.6B |
| Earning after tax | -8.29%1.36B | 12.42%3.34B | 9.61%1.48B | 1.75%2.97B | 11.54%1.35B | -11.81%2.92B | -15.35%1.21B | 27.26%3.31B | 39.53%1.43B | 0.23%2.6B |
| Special items of profit attributable to shareholders | -33.02%359M | 222.58%228M | 44.47%536M | -431.43%-186M | 16.30%371M | -109.28%-35M | -42.31%319M | 387.79%377M | 156.02%553M | -148.88%-131M |
| Profit attributable to shareholders | 5.70%1B | -1.43%3.11B | -3.56%947M | 6.84%3.16B | 9.84%982M | 0.72%2.95B | 1.59%894M | 7.36%2.93B | 8.51%880M | 17.40%2.73B |
| Basic earnings per share | 5.69%0.1133 | -1.43%0.3521 | -3.51%0.1072 | 6.85%0.3572 | 9.78%0.1111 | 0.72%0.3343 | 1.61%0.1012 | 7.34%0.3319 | 8.50%0.0996 | 17.43%0.3092 |
| Diluted earnings per share | 5.69%0.1133 | -1.43%0.3521 | -3.51%0.1072 | 6.85%0.3572 | 9.78%0.1111 | 0.72%0.3343 | 1.61%0.1012 | 7.34%0.3319 | 8.50%0.0996 | 17.43%0.3092 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.